238 results
Page 5 of 12
10-K
EX-10.20
i9njfy3k7hz
12 Feb 18
Annual report
12:00am
10-K
EX-10.21
pd03xvne3
12 Feb 18
Annual report
12:00am
10-K
EX-10.31
5hri2eo2o8hm3hajy
12 Feb 18
Annual report
12:00am
10-K
EX-10.39
i8xvkh2sp4
12 Feb 18
Annual report
12:00am
10-K
EX-10.44
6e2q2
12 Feb 18
Annual report
12:00am
424B5
dapppl
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
qn2zwdc8za9wlxv4
13 Jul 16
First Amendment to Master Purchase Agreement
12:00am
6-K
z6d8stk6goh b2s
13 Jul 16
Current report (foreign)
12:00am
424B5
s005e6kq
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
tb1 7bvqe7
30 Nov 15
Current report (foreign)
12:00am
424B5
nt0n6x
30 Nov 15
Prospectus supplement for primary offering
12:00am
425
k2iqs2k c61
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
g43rt
21 Apr 15
Teva Proposes to Acquire Mylan for $82.00 Per Share In Cash and Stock
12:00am
425
6vysaij0czsr
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
nev5xcdw3932p6d
2 Mar 15
Teva Announces Sale of Sellersville, PA Facility
12:00am
6-K
7q35z1x5lmkfc xoy
30 Oct 14
Current report (foreign)
12:00am